According to the latest report by IMARC Group, titled Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the market to reach US$ 925 Billion by 2027, exhibiting a CAGR of 4.9% during 2022-2027.

The introduction of recombinant DNA technology, or genetic engineering, involves altering genetic material outside an organism and obtaining enhanced and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources with a desirable gene sequence through an appropriate vector. Besides this, recombinant DNA technology aids in the safe, affordable, and sufficient production of vital proteins needed for dietary purposes and fighting health problems. Consequently, it has multidisciplinary applications and a remarkable potential to improve health, food resources, resistance to divergent adverse environmental effects, etc.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Recombinant DNA Technology Market Trends:

Recombinant DNA technology is being increasingly utilized for treating different health conditions, primarily by developing new vaccines and pharma products. This, along with the improving treatment strategies due to the developing diagnostics kits, monitoring devices, new therapeutic approaches, etc., are among the significant factors fueling the market. Moreover, the rising number of research activities conducted on genetically modified organisms (GMO), which include microorganisms considered as bio degraders and clean fuel producers, is also propelling the market for recombinant DNA technology. Additionally, the escalating integration of recombinant DNA technology with effective gene therapy for replacing defective genes with normal ones is further anticipated to stimulate the market growth in the coming years.

Request Free Sample Report:

Global Recombinant DNA Technology Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).

The report has segmented the market on the basis on region, product, component, application, end user.

Breakup by Product:

  • Medical
  • Therapeutic Agent
  • Human Protein
  • Vaccines
  • Non-Medical
  • Biotech Crops
  • Specialty Chemicals
  • Others

Breakup by Component:

  • Expression System
  • Cloning Vector

Breakup by Application:

  • Food and Agriculture
  • Health and Disease
  • Environment
  • Others

Breakup by End User:

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Others

Breakup by Region:

  • North America:(United States, Canada
  • Asia-Pacific:(China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America;(Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800